Artiva Biotherapeutics, Inc. Common Stock (ARTV) earnings · $37.3M cap
These earnings events as JSON? API free 100/dayArtiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
This ARTV earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
When the next ARTV 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ARTV research stays on the stock page; the tape stays on the quote page.
ARTV earnings FAQ
What is ARTV's latest net income?
Latest cached Artiva Biotherapeutics, Inc. Common Stock (ARTV) net income was -$83.9M. Statements: https://lician.com/financials/artv
What is ARTV's latest diluted EPS?
Latest cached Artiva Biotherapeutics, Inc. Common Stock (ARTV) diluted EPS for Dec 31, 2025 was -$3.43.
What period does the latest ARTV earnings print cover?
The latest cached Artiva Biotherapeutics, Inc. Common Stock (ARTV) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are ARTV earnings listed?
Cached earnings facts for Artiva Biotherapeutics, Inc. Common Stock (ARTV) are listed at https://lician.com/earnings/artv. Statements: https://lician.com/financials/artv
Not investment advice.